Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX   US23283K1051

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
1.2(c) 1.24(c) 1.19(c) 1.18(c) 1.17 Last
2 508 674 3 043 697 3 686 902 1 745 273 929 834 Volume
+0.84% +3.33% -4.03% -0.84% -0.85% Change
More quotes
Financials ($)
Sales 2015 12,2 M
EBIT 2015 -23,0 M
Net income 2015 -25,7 M
Debt 2015 -
Yield 2015 -
Sales 2016 31,6 M
EBIT 2016 -11,3 M
Net income 2016 -13,4 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 10,5x
Capi. / Sales 2016 4,04x
Capitalization 128 M
More Financials
Company
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells to treat cardiovascular disease and repair soft tissue defects.It automates the extraction and preparation of clinical grade adipose-derived stem and regenerative cells using device,... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
03/26 CYTORI THERAPEUTICS : Presents Thermal Burn Data at the 2015 American Burn Assoc..
03/25 CYTORI THERAPEUTICS : Launches Celase® GMP Product
03/25 CYTORI THERAPEUTICS : Launches Celase GMP Product
03/23 CYTORI THERAPEUTICS : Presents Thermal Burn Data at the 2015 American Burn Assoc..
03/21 CYTORI THERAPEUTICS : Reports Fourth Quarter and Full Year 2014 Business and Fin..
03/18 CYTORI THERAPEUTICS : Reports Fourth Quarter and Full Year 2014 Business and Fin..
03/18 CYTORI THERAPEUTICS : Entry into a Material Definitive Agreement (form 8-K)
03/17 CYTORI THERAPEUTICS : Posts Fourth Quarter and Full Year 2014 Business and Finan..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
11:22a ZIMMER : Mar 27, 2015 Zimmer Debuts New Modular External Fixation System
11:22a ZIMMER : Mar 27, 2015 Zimmer Celebrates Key Milestones For NexGen Complete Knee ..
07:07a TERUMO : FAMHP advises patients to not suspend nor stop any treatments
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
03/17 PREMARKET GAINERS / LOSERS AS OF 9 : 15 am
03/17 Borrow Costs Elevated On CorMedix
03/13 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q4 2014 Results -- Earnings C..
03/13 Premarket Gainers / Losers
03/12 Cytori Therapeutics EPS in-line, misses on revenue


Comments 
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF